Granules India formed an agreement with Hubei Biocause Heilen Pharmaceutical company to sell 3.3 crore equity shares worth RMB 109M held by its joint venture partner, Granules-Biocause Pharmaceutical Co. Limited.
Feedback
GRANULES 
Reputation: 29,954 • Dec 16, 2019 3:43 PM
1 Vote
Comment
Share
View Votes